CoChat
Cited by 202

The DOI matches its Crossref record.

Pharmacokinetic Considerations in Obesity

Blouin, Robert A., Warren, Graham W. · 1999 · Journal of Pharmaceutical Sciences

Abstract

Obesity is a disease characterized as a condition resulting from the excess accumulation of body fat. In conjunction with increased stores of body fat, obesity has also been associated with increased mortality influenced by increased incidence of hypertension, atherosclerosis and coronary artery disease, diabetes, cancers of the breast, colon, prostate, endometrium, ovary, and cervix, and decreased overall survivability when compared with nonobese counterparts.1-5 As a consequence, obese individuals generally require more therapeutic intervention earlier in life than nonobese individuals. A very important consideration for pharmacological treatment of obese individuals is the possible discrepancies between obese and nonobese individuals in pharmacokinetic and/or pharmacodynamic activities of a drug. Changes in pharmacokinetic parameters such as volume of distribution or clearance can significantly alter the pharmacologic impact of a drug; therefore, it is important to characterize the properties of drugs in obese individuals. The direct causes of obesity are difficult to discern due to the plethora of physiological changes associated with obesity. Furthermore, characterizing metabolic and genetic differences between obese and nonobese individuals has proven complex resulting in broad scale attempts to study genetic and nutritional models of obesity in animals. These animal models can be used to help determine the possible causes and effects of obesity in humans resulting in possible agents to attenuate the causes and effects of obesity. There have been several references reviewing the causes and pharmacological implications of obesity.6-12 These show the effects of obesity on the pharmacokinetics of drugs in obese subjects; however, there have been considerable advances in the understanding of obesity, particularly in the genetic causes and changes in genetic expression asssociated with obesity. This article will attempt to comprehensively review current knowledge regarding obesity ranging from genetic and nutritional animal studies to pharmacokinetic studies of specific drugs in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/js980173a

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Blouin, R. A., & Warren, G. W.
Venue
Journal of Pharmaceutical Sciences
Published
1999-01
Volume
88
Issue
1
Pages
1-7
ISSN
0022-3549 (ISSN-L)
OpenAlex
W2110078378
Cited by
202
References
0
FWCI
1.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.